<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="4715" OLDID="9628" TOPICS="NO">
<DATE>13-MAR-1987 07:30:03.68</DATE>
<TOPICS/>
<PLACES><D>netherlands</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0512 reute
u f BC-AKZO-PHARMA-UNIT-IN-V   03-13 0108</UNKNOWN>
<TEXT> 
<TITLE>AKZO PHARMA UNIT IN VENTURE WITH BIOTECHNOLOGY</TITLE>
<DATELINE>    OSS, Netherlands, March 13 - </DATELINE><BODY>&lt;Organon International BV&gt;, a
subsidiary of the pharmaceutical division of Dutch chemical
group Akzo NV &lt;AKZO.AS&gt;, said it agreed to cooperate in drug
research and development with &lt;California Biotechnology Inc&gt;.
    Organon will receive world clinical development and
marketing rights for any products pioneered under the agreement
with the U.S. Firm, an Organon spokesman said. He gave no
further details.
    The two companies will be looking at drugs to treat
ailments of the nervous system like Alzheimer's disease which
often affects the elderly, he said.
 REUTER
 </BODY></TEXT>
</REUTERS>